Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Accumulated Expenses (2017 - 2022)

Historic Other Accumulated Expenses for Lipocine (LPCN) over the last 4 years, with Q1 2022 value amounting to $1.0 million.

  • Lipocine's Other Accumulated Expenses changed N/A to $1.0 million in Q1 2022 from the same period last year, while for Mar 2022 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that Lipocine reported Other Accumulated Expenses of $1.0 million as of Q1 2022.
  • Lipocine's Other Accumulated Expenses' 5-year high stood at $4.2 million during Q1 2018, with a 5-year trough of $1.0 million in Q3 2021.
  • Over the past 3 years, Lipocine's median Other Accumulated Expenses value was $1.0 million (recorded in 2021), while the average stood at $2.0 million.